Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 687, Issue 1-2, 2010, Pages 17-27

  Little, M P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bystander effect; Cancer; Cardiovascular disease; Dose response; Genomic instability; Japanese atomic bomb survivors; Non DNA targeted effects

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; ATOMIC BOMB SURVIVOR; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CHROMOSOME ABERRATION; DOUBLE STRANDED DNA BREAK; GASTROINTESTINAL DISEASE; GENOMIC INSTABILITY; HIGH RISK POPULATION; HORMESIS; HUMAN; INFLAMMATION; IONIZING RADIATION; LEUKEMIA; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION HAZARD; RADIATION RESPONSE; RESPIRATORY TRACT DISEASE; SOMATIC MUTATION; THYROID CANCER;

ANIMALS; BYSTANDER EFFECT; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENVIRONMENTAL EXPOSURE; HUMANS; JAPAN; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WEAPONS; RADIATION EFFECTS; RISK; SURVIVORS;

EID: 77951296972     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.01.008     Document Type: Article

References (151)

1. Stevens L.G. Injurious effects on the skin. Br. Med. J. 1896, 1:998.
2. Gilchrist T.C. A case of dermatitis due to the X-rays. Bull. Johns Hopkins Hosp. 1897, 8(71):17-22.
3. Frieben A. Demonstration eines Cancroids des rechten Handrückens, das sich nach langdauernder Einwirkung von Röntgenstrahlen bei einem 33 jährigen Mann entwickelt hatte. Fortschr. Röntgenstr. 1902, 6:106.
4. U.S.National Academy of Sciences National Research Council Committee to assess health risks from exposure to low levels of ionizing radiation. Health Risks from Exposure to Low Levels of Ionizing Radiation. BEIR VII Phase 2 2006, The National Academies Press, Washington, DC.
5. International Commission on Radiological Protection ICRP Publication 103. The 2007 recommendations of the International Commission on Radiological Protection. Annals ICRP, 37(2-4) 2007, 1-332. ICRP Publication 103, Pergamon, Oxford.
6. United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR 2006 Report. Annex A. Epidemiological studies of radiation and cancer. United Nations, New York (2008).
7. Wong F.L., Yamada M., Sasaki H., Kodama K., Akiba S., Shimaoka K., Hosoda Y. Noncancer disease incidence in the atomic bomb survivors: 1958-1986. Radiat. Res. 1993, 135:418-430.
8. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 2003, 160:381-407.
9. Yamada M., Wong F.L., Fujiwara S., Akahoshi M., Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat. Res. 2004, 161:622-632.
10. McGale P., Darby S.C. Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiat. Res. 2005, 163. 247-257, 711.
11. Howe G.R., Zablotska L.B., Fix J.J., Egel J., Buchanan J. Analysis of the mortality experience amongst U.S. nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat. Res. 2004, 162:517-526.
12. Ivanov V.K., Maksioutov M.A., Chekin S.Y., Petrov A.V., Biryukov A.P., Kruglova Z.G., Matyash V.A., Tsyb A.F., Manton K.G., Kravchenko J.S. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Phys. 2006, 90:199-207.
13. McGeoghegan D., Binks K., Gillies M., Jones S., Whaley S. The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005. Int. J. Epidemiol. 2008, 37:506-518.
14. Muirhead C.R., O'Hagan J.A., Haylock R.G.E., Phillipson M.A., Willcock T., Berridge G.L.C., Zhang W. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br. J. Cancer 2009, 100:206-212.
15. Azizova T.V., Muirhead C.R. Epidemiological evidence for circulatory diseases-occupational exposure. Proceedings of the EU Scientific Seminar " Emerging evidence for radiation induced circulatory diseases" 2009.
16. Vrijheid M., Cardis E., Ashmore P., Auvinen A., Bae J.-M., Engels H., Gilbert E., Gulis G., Habib R.R., Howe G., Kurtinaitis J., Malker H., Muirhead C.R., Richardson D.B., Rodriguez-Artalejo F., Rogel A., Schubauer-Berrigan M., Tardy M., Telle-Lamberton M., Usel M., Veress K. Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int. J. Epidemiol. 2007, 36:1126-1135.
17. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). UNSCEAR 2006 Report. Annex B. Epidemiological evaluation of cardiovascular disease and other non-cancer diseases following radiation exposure. United Nations, New York (2008).
18. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), Sources and effects of ionizing radiation. UNSCEAR 1993 Report to the General Assembly, with scientific annexes. United Nations, New York (1993).
19. Morgan W.F. Non-targeted and delayed effects of exposure to ionizing radiation. I. Radiation-induced genomic instability and bystander effects in vitro. Radiat. Res. 2003, 159:567-580.
20. Morgan W.F. Non-targeted and delayed effects of exposure to ionizing radiation. II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat. Res. 2003, 159:581-596.
21. International Commission on Radiological Protection Low-dose extrapolation of radiation related cancer risk. Annals ICRP 35(4) 2006, 1-141. Pergamon, Oxford, ICRP Publication 99.
22. Joiner M.C., Marples B., Lambin P., Short S.C., Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:379-389.
23. Joiner M.C., Johns H. Renal damage in the mouse: the response to very small doses per fraction. Radiat. Res. 1988, 114:385-398.
24. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) Sources and Effects of Ionizing Radiation. UNSCEAR 1994 Report to the General Assembly with Scientific Annexes 1994, United Nations, New York.
25. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) UNSCEAR 2006 Report Annex C. Non-targeted and Delayed Effects of Exposure to Ionizing Radiation 2008, United Nations, New York.
26. Tubiana M., Kaminski J., Yang C., Feinendegen L. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data (editorial). Radiology 2009, 251:13-22.
27. Little M.P., Wakeford R., Tawn E.J., Bouffler S.D., Berrington de Gonzalez A. Risks associated with low doses and low dose-rates of ionizing radiation: why linearity may be (almost) the best we can do (editorial). Radiology 2009, 251:6-12.
28. Little M.P., Tawn E.J., Tzoulaki I., Wakeford R., Hildebrandt G., Paris F., Tapio S., Elliott P. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat. Res. 2008, 169:99-109.
29. Little M.P. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors. Int. J. Radiat. Biol. 2001, 77. 431-464, 745-760.
30. Little M.P. Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol. 2001, 2:212-220.
31. Pierce D.A., Vaeth M. The shape of the cancer mortality dose-response curve for the A-bomb survivors. Radiat. Res. 1991, 126:36-42.
32. Little M.P., Muirhead C.R. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. Int. J. Radiat. Biol. 1996, 70:83-94.
33. Little M.P., Muirhead C.R. Curvature in the cancer mortality dose-response in Japanese atomic bomb survivors: absence of evidence of threshold. Int. J. Radiat. Biol. 1998, 74:471-480.
34. Preston D.L., Pierce D.A., Shimizu Y., Cullings H.M., Fujita S., Funamoto S., Kodama K. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 2004, 162:377-389.
35. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., Mabuchi K., Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 2007, 168:1-64.
36. Little M.P., Charles M.W. The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors. Int. J. Radiat. Biol. 1997, 71:589-602.
37. Rowland R.E., Stehney A.F., Lucas H.F. Dose-response relationships for female radium dial workers. Radiat. Res. 1978, 76:368-383.
38. Thomas R.G. The US radium luminisers: a case for a policy of 'below regulatory concern'. J. Radiol. Prot. 1994, 14:141-153.
39. Little M.P., Hoel D.G., Molitor J., Boice J.D., Wakeford R., Muirhead C.R. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report. Radiat. Res. 2008, 169:660-676.
40. Preston D.L., Mattsson A., Holmberg E., Shore R., Hildreth N.G., Boice J.D. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat. Res. 2002, 158:220-235. 158, 666.
41. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
42. Mollà M., Panés J., Casadevall M., Salas A., Conill C., Biete A., Anderson D.C., Granger D.N., Piqué J.M. Influence of dose-rate on inflammatory damage and adhesion molecule expression after abdominal radiation in the rat. Int. J. Radiat. Oncol. Biol. Phys. 1999, 45:1011-1018.
43. National Academy of Sciences U.S. National Research Council, Committee on Health Risks of Exposure to Radon (BEIR VI). Health Effects of Exposure to Radon 1999, National Academy Press, Washington, DC.
44. Little M.P. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model. Int. J. Radiat. Biol. 2002, 78:145-163.
45. Brenner D.J., Hall E.J. The inverse dose-rate effect for oncogenic transformation by neutrons and charged particles: a plausible interpretation consistent with published data. Int. J. Radiat. Biol. 1990, 58:745-758.
46. Little M.P., Hawkins M.M., Charles M.W., Hildreth N.G. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks. Radiat. Res. 1992, 132:207-221.
47. Boice J.D., Blettner M., Kleinerman R.A., Stovall M., Moloney W.C., Engholm G., Austin D.F., Bosch A., Cookfair D.L., Krementz E.T., et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J. Natl. Cancer Inst. 1987, 79:1295-1311.
48. Thomas D.C., Blettner M., Day N.E. Use of external rates in nested case-control studies with application to the International Radiation Study of Cervical Cancer patients. Biometrics 1992, 48:781-794.
49. Weiss H.A., Darby S.C., Fearn T., Doll R. Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat. Res. 1995, 142:1-11.
50. Little M.P., Weiss H.A., Boice J.D., Darby S.C., Day N.E., Muirhead C.R. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat. Res. 1999, 152:280-292. 153, 243.
51. Little M.P., Muirhead C.R. Absence of evidence for threshold departures from linear-quadratic curvature in the Japanese A-bomb cancer incidence and mortality data. Int. J. Low Radiat. 2004, 1:242-255.
52. Pierce D.A., Preston D.L. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res. 2000, 154:178-186.
53. Land C.E. Uncertainty, low-dose extrapolation and the threshold hypothesis. J. Radiol. Prot. 2002, 22:A129-135.
54. Stewart A.M., Webb K.W., Hewitt D. A survey of childhood malignancies. Br. Med. J. 1958, 1:1495-1508.
55. Monson R.R., MacMahon B. Prenatal X-ray exposure and cancer in children. Radiation Carcinogenesis: Epidemiology and Biological Significance 1984, 97-105. Raven Press, New York. J.D. Boice, J.F. Fraumeni (Eds.).
56. Harvey E.B., Boice J.D., Honeyman M., Flannery J.T. Prenatal X-ray exposure and childhood cancer in twins. N. Engl. J. Med. 1985, 312:541-545.
57. Boice J.D., Miller R.W. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology 1999, 59:227-233.
58. International Commission on Radiological Protection (ICRP) Biological effects after prenatal irradiation (embryo and fetus). Annals ICRP 33(1-2) 2003, 1-206. Pergamon, Oxford, ICRP Publication 90.
59. Doll R., Wakeford R. Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 1997, 70:130-139.
60. Wakeford R., Little M.P. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int. J. Radiat. Biol. 2003, 79:293-309.
61. Boice J.D., Preston D., Davis F.G., Monson R.R. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat. Res. 1991, 125:214-222.
62. Howe G.R., McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat. Res. 1996, 145:694-707.
63. Little M.P., Boice J.D. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat. Res. 1999, 151:218-224.
64. National Council on Radiation Protection and Measurements. Influence of dose and its distribution in time on dose-response relationships for low-LET radiations. NCRP Report No. 64. NCRP, Bethesda, MD (1980).
65. Davis F.G., Boice J.D., Hrubec Z., Monson R.R. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 1989, 49:6130-6136.
66. Howe G.R. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat. Res. 1995, 142:295-304.
67. Ronckers C.M., Doody M.M., Lonstein J.E., Stovall M., Land C.E. Multiple diagnostic X-rays for spine deformities and risk of breast cancer. Cancer Epidemiol. Biomark. Prevent. 2008, 17:605-613.
68. Ron E., Lubin J.H., Shore R.E., Mabuchi K., Modan B., Pottern L.M., Schneider A.B., Tucker M.A., Boice J.D. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 1995, 141:259-277.
69. Shore R.E., Moseson M., Harley N., Pasternack B.S. Tumors and other diseases following childhood X-ray treatment for ringworm of the scalp (tinea capitis). Health Phys. 2003, 85:404-408.
70. Lindberg S., Karlsson P., Arvidsson B., Holmberg E., Lundberg L.M., Wallgren A. Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol. 1995, 34:735-740.
71. Lundell M., Hakulinen T., Holm L.-E. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat. Res. 1994, 140:334-339.
72. Cardis E., Vrijheid M., Blettner M., Gilbert E., Hakama M., Hill C., Howe G., Kaldor J., et al. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. Br. Med. J. 2005, 331:77-80.
73. International Commission on Radiological Protection (ICRP). Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Annals ICRP 24(1-3), 1-482, Pergamon, Oxford (1994).
74. Land C.E. Estimating cancer risks from low doses of ionizing radiation. Science 1980, 209:1197-1203.
75. Bonassi S., Ugolini D., Kirsch-Volders M., Stromberg U., Vermeulen R., Tucker J.D. Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ. Mol. Mutagen. 2005, 45:258-270.
76. Norppa H., Bonassi S., Hansteen I.L., Hagmar L., Stromberg U., Rossner P., Boffetta P., Lindholm C., Gundy S., Lazutka J., Cebulska-Wasilewska A., Fabianova E., Sram R.J., Knudsen L.E., Barale R., Fucic A. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res. 2006, 600:37-45.
77. Boffetta P., van der Hel O., Norppa H., Fabianova E., Fucic A., Gundy S., Lazutka J., Cebulska-Wasilewska A., Puskailerova D., Znaor A., Kelecsenyi Z., Kurtinaitis J., Rachtan J., Forni A., Vermeulen R., Bonassi S. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am. J. Epidemiol. 2007, 165:36-43.
78. Tawn E.J., Whitehouse C.A., Tarone R.E. FISH chromosome aberration analysis on retired radiation workers from the Sellafield nuclear facility. Radiat. Res. 2004, 162:249-256.
79. Sasaki M.S., Nomura T., Ejima Y., Utsumi H., Endo S., Saito I., Itoh T., Hoshi M. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment. Radiat. Res. 2008, 170:101-117.
80. IAEA, Cytogenetic Analysis for Radiation Dose Assessment. A Manual, IAEA Technical Report Series No. 405. International Atomic Energy Agency, Vienna (2001).
81. Bhatti P., Doody M.M., Preston D.L., Kampa D., Ron E., Weinstock R.W., Simon S., Edwards A.A., Sigurdson A.J. Increased frequency of chromosome translocations associated with diagnostic X-ray examinations. Radiat. Res. 2008, 170:149-155.
82. Edwards A.A., Lloyd D.C. Risks from ionising radiation: deterministic effects. J. Radiol. Prot. 1998, 18:175-183.
83. Harris H. A long view of fashions in cancer research. Bioessays 2005, 27:833-838.
84. National Council on Radiation Protection and Measurements. Evaluation of the linear-nonthreshold dose-response model for ionizing radiation. NCRP Report No. 136. NCRP, Bethesda, MD (2001).
85. Brenner D.J., Doll R., Goodhead D.T., Hall E.J., Land C.E., Little J.B., Lubin J.H., Preston D.L., Preston R.J., Puskin J.S., Ron E., Sachs R.K., Samet J.M., Setlow R.B., Zaider M. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13761-13766.
86. Brenner D.J., Little J.B., Sachs R.K. The bystander effect in radiation oncogenesis. II. A quantitative model. Radiat. Res. 2001, 155:402-408.
87. Mothersill C., Smith R.W., Agnihotri N., Seymour C.B. Characterisation of a radiation-induced stress response communicated in vivo between zebrafish. Environ. Sci. Technol. 2007, 41:3382-3387.
88. Mancuso M., Pasquali E., Leonardi S., Tanori M., Rebessi S., Di Majo V., Pazzaglia S., Toni M.-P., Pimpinella M., Covelli V., Saran A. Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12445-12450.
89. Little M.P., Wakeford R. The bystander effect in C3H 10T1/2 cells and radon-induced lung cancer. Radiat. Res. 2001, 156:695-699.
90. Nakanishi M., Tanaka K., Shintani T., Takahashi T., Kamada N. Chromosomal instability in acute myelocytic leukemia and myelodysplastic syndrome patients among atomic bomb survivors. J. Radiat. Res. 1999, 40:159-167.
91. Nakanishi M., Tanaka K., Takahashi T., Kyo T., Dohy H., Fujiwara M., Kamada N. Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors. Int. J. Radiat. Biol. 2001, 77:687-694.
92. Little M.P. Comments on the paper: microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors (letter to the editor). Int. J. Radiat. Biol. 2002, 78:441-443.
93. Cox R., Edwards A.A. Comments on the paper: microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors-and related cytogenetic data (letter to the editor). Int. J. Radiat. Biol. 2002, 78:443-445.
94. Littlefield L.G., Travis L.B., Sayer A.M., Voelz G.L., Jensen R.H., Boice J.D. Cumulative genetic damage in hematopoietic stem cells in a patient with a 40-year exposure to alpha particles emitted by thorium dioxide. Radiat. Res. 1997, 148:135-144.
95. Salomaa S., Holmberg K., Lindholm C., Mustonen R., Tekkel M., Veidebaum T., Lambert B. Chromosomal instability in in vivo radiation exposed subjects. Int. J. Radiat. Biol. 1998, 74:771-779.
96. Tawn E.J., Whitehouse C.A., Martin F.A. Sequential chromosome aberration analysis following radiotherapy-no evidence for enhanced genomic instability. Mutat. Res. 2000, 465:45-51.
97. Whitehouse C.A., Tawn E.J. No evidence for chromosomal instability in radiation workers with in vivo exposure to plutonium. Radiat. Res. 2001, 156:467-475.
98. Kryscio A., Ulrich Müller W.-U., Wojcik A., Kotschy N., Grobelny S., Streffer C. A cytogenetic analysis of the long-term effect of uranium mining on peripheral lymphocytes using the micronucleus-centromere assay. Int. J. Radiat. Biol. 2001, 77:1087-1093.
99. Schultz-Hector S., Trott K.-R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:10-18.
100. Little M.P. Threshold and other departures from linear-quadratic curvature in the non-cancer mortality dose-response curve in the Japanese atomic bomb survivors. Radiat. Environ. Biophys. 2004, 43:67-75.
101. M.P. Little, E.J. Tawn, I. Tzoulaki, R. Wakeford, G. Hildebrandt, F. Paris, S. Tapio, P. Elliott, Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat. Environ. Biophys. (in press), doi:10.1007/s00411-009-0250-z.
102. Andreassi M.G., Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc. Med. 2003, 13:270-275.
103. Botto N., Berti S., Manfredi S., Al-Jabri A., Federici C., Clerico A., Ciofini E., Biagini A., Andreassi M.G. Detection of mtDNA with 4977bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat. Res. 2005, 570:81-88.
104. Mahmoudi M., Mercer J., Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc. Res. 2006, 71:259-268.
105. McGale P., Darby S.C., Commentary: A dose-response relationship for radiation-induced heart disease-current issues and future prospects. Int. J. Epidemiol. 2008, 37:518-523.
106. World Health Organization WHO Mortality Database 2006, WHO Statistical Information System (WHOSIS).
107. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
108. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000, 342:836-843.
109. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., Curhan G.C., Rifai N., Cannuscio C.C., Stampfer M.D., Rimm E.B. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 2004, 351:2599-2610.
110. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005, 112:976-983.
111. Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113:2335-2362.
112. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
113. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U.S.A. 1973, 70:1753-1756.
114. Schwartz S.M., Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 1998, 49:437-460.
115. Andreassi M.G. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat. Res. 2003, 543:67-86.
116. Mercer J., Mahmoudi M., Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat. Res. 2007, 621:75-86.
117. Murgia E., Maggini V., Barale R., Rossi A.M. Micronuclei, genetic polymorphisms and cardiovascular disease mortality in a nested case-control study in Italy. Mutat. Res. 2007, 621:113-118.
118. Ramos K.S., Partridge C.R., Teneng I. Genetic and molecular mechanisms of chemical atherogenesis. Mutat. Res. 2007, 621:18-30.
119. Matthews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., Goddard M., Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 2006, 99:156-164.
120. McCaffrey T.A., Du B.H., Consigli S., Szabo P., Bray P.J., Hartner L., Weksler B.B., Sanborn T.A., Bergman G., Bush H.L. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J. Clin. Invest. 1997, 100:2182-2188.
121. Bobik A., Agrotis A., Kanellakis P., Dilley R., Krushinsky A., Smirnov V., Tararak E., Condron M., Kostolias G. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-β in fibrofatty lesion development. Circulation 1999, 99:2883-2891.
122. Clark K.J., Cary N.R., Grace A.A., Metcalfe J.C. Microsatellite mutation of type II transforming growth factor-β receptor is rare in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 2001, 21:555-559.
123. Chung I.-M., Schwartz S.M., Murry C.E. Clonal architecture of normal and atherosclerotic aorta-implications for atherogenesis and vascular development. Am. J. Pathol. 1998, 152:913-923.
124. Kavurma M.M., Figg N., Bennett M.R., Mercer J., Khachigian L.M., Littlewood T.D. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment. Biochem. J. 2007, 407:79-87.
125. Braganza D.M., Bennett M.R. New insights into atherosclerotic plaque rupture. Postgrad. Med. J. 2001, 77:94-98.
126. Hallahan D., Clark E.T., Kuchibhotla J., Gewertz B.L., Collins T. E-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochem. Biophys. Res. Commun. 1995, 217:784-795.
127. Hallahan D., Kuchibhotla J., Wyble C. Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Res. 1996, 56:5150-5155.
128. Quarmby S., Hunter R.D., Kumar S. Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells. Anticancer Res. 2000, 20:3375-3381.
129. Hallahan D.E., Virudachalam S. Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6432-6437.
130. Heckmann M., Douwes K., Peter R., Degitz K. Vascular activation of adhesion molecule mRNA and cell surface expression by ionizing radiation. Exp. Cell. Res. 1998, 238:148-154.
131. Gaugler M.-H., Squiban C., Claraz M., Schweitzer K., Weksler B., Gourmelon P., van der Meeren A. Characterization of the response of human bone marrow endothelial cells to in vitro irradiation. Br. J. Haematol. 1998, 103:980-989.
132. Woloschak G.E., Chang-Liu C.-M., Jones P.S., Jones C.A. Modulation of gene expression in Syrian hamster embryo cells following ionizing radiation. Cancer Res. 1990, 50:339-344.
133. Kern P.M., Keilholz L., Forster C., Hallmann R., Herrmann M., Seegenschmiedt M.-H. Low-dose radiotherapy selectively reduces adhesion of peripheral blood mononuclear cells to endothelium in vitro. Radiother. Oncol. 2000, 54:273-282.
134. 1-induced down-regulation of leukocyte/endothelial cell adhesion. Int. J. Radiat. Biol. 2002, 78:711-719.
135. Hildebrandt G., Seed M.P., Freemantle C.N., Alam C.A.S., Colville-Nash P.R., Trott K.R. Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int. J. Radiat. Biol. 1998, 74:367-378.
136. Hallahan D.E., Virudachalam S. Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Res. 1997, 57:2096-2099.
137. Arenas M., Gil F., Gironella M., Hernández V., Jorcano S., Biete A., Piqué J.M., Panés J. Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:560-567.
138. Hayashi T., Kusunoki Y., Hakoda M., Morishita Y., Kubo Y., Maki M., Kasagi F., Kodama K., Macphee D.G., Kyoizumi S. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int. J. Radiat. Biol. 2003, 79:129-136.
139. Hayashi T., Morishita Y., Kubo Y., Kusunoki Y., Hayashi I., Kasagi F., Hakoda M., Kyoizumi S., Nakachi K. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am. J. Med. 2005, 118:83-86.
140. Ridker P.M. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence?. Circulation 1998, 97:1671-1674.
141. Gura T. Infections: a cause of artery-clogging plaques?. Science 1998, 281. 35-37, 923.
142. Kusunoki Y., Kyoizumi S., Hirai Y., Suzuki T., Nakashima E., Kodama K., Seyama T. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiat. Res. 1998, 150:227-236.
143. Kusunoki Y., Kyoizumi S., Yamaoka M., Kasagi F., Kodama K., Seyama T. Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction. Radiat. Res. 1999, 152:539-543.
144. Rees G.S., Daniel C.P., Morris S.D., Whitehouse C.A., Binks K., MacGregor D.H., Tawn E.J. Occupational exposure to ionizing radiation has no effect on T- and B-cell total counts or percentages of helper, cytotoxic and activated T-cell subsets in the peripheral circulation of male radiation workers. Int. J. Radiat. Biol. 2004, 80:493-498.
145. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
146. Little M.P., Gola A., Tzoulaki I. A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure. PLoS Comput. Biol. 2009, 5(10):e1000539. 10.1371/journal.pcbi.1000539.
147. Talbott E.O., Youk A.O., McHugh-Pemu K.P., Zborowski J.V. Long-term follow-up of the residents of the Three Mile Island accident area: 1979-1998. Environ. Health Perspect. 2003, 111:341-348.
148. Kreuzer M., Kreisheimer M., Kandel M., Schnelzer M., Tschense A., Grosche B. Mortality from cardiovascular diseases in the German uranium minors cohort study, 1946-1998. Radiat. Environ. Biophys. 2006, 45:159-166.
149. Darby S.C., Doll R., Gill S.K., Smith P.G. Long-term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer 1987, 55:179-190.
150. Carr Z.A., Land C.E., Kleinerman R.A., Weinstock R.W., Stovall M., Griem M.L., Mabuchi K. Coronary heart disease after radiotherapy for peptic ulcer disease. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61:842-850.
151. Shimizu Y., Kodama K., Nishi N., Kasagi F., Suyama A., Soda M., Grant E.J., Sugiyama H., Sakata R., Moriwaki H., Hayashi M., Konda M., Shore R.E. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. Br. Med. J. 2010, 340:b5349.